(E–F), Migration of fibrocytes from patients with COPD in response to CD8+ T cells supernatants from control subjects (CtlNS) or COPD patients (COPD), in the presence of 200 nM Reparixin (+) or corresponding vehicle (−) (E), and in the presence of 1 μg/mL blocking antibody for CXCL8 (+) or control antibody (−) (F). This evidence concerns the gene CXCL8 and chronic obstructive pulmonary disease.